Literature DB >> 12441723

Ultrasound biomicroscopy in chronic ocular hypotony: its impact on diagnosis and management.

Sigrid Roters1, Peter Szurman, Bert F Engels, Karl U Bartz-Schmidt, Gunter K Krieglstein.   

Abstract

PURPOSE: To determine the value of ultrasound biomicroscopy (UBM) in the assessment of ocular hypotony in cases where the underlying pathologic mechanism remains unclear after extensive clinical examination.
METHODS: In a retrospective study, the records of 60 patients who had undergone UBM to elucidate the underlying structural abnormalities of chronic ocular hypotony (intraocular pressure of 0-8 mmHg) were evaluated. Most patients (47 of 60 eyes) had a history of intraocular surgery or of other ocular diseases (e.g., uveitis), and after careful clinical examination, the cause had remained unclear. All patients were observed up for a minimum of 12 months.
RESULTS: The associated pathoanatomy of the hypotony was demonstrated by UBM in 95% of the cases. Ciliary body abnormalities were present in 80% of the eyes. Therapeutic intervention was associated with restoration of normal ocular pressure in 50% of the cases. Often more than one intervention was necessary. A long duration of hypotony did not impede reaching the therapeutic goal of normalizing intraocular pressure and preventing phthisis.
CONCLUSIONS: Ultrasound biomicroscopy is a new tool for detecting the underlying structural abnormalities in ocular hypotony. In cases where clinical examination is not sufficient it can be of great help in deciding on a course of treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12441723     DOI: 10.1097/00006982-200210000-00008

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

Review 1.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

Review 2.  Current approach in the diagnosis and management of panuveitis.

Authors:  Reema Bansal; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

3.  Surgical treatment for 42 patients with traumatic annular ciliochoroidal detachment.

Authors:  Jian-Gang Yang; Guo-Min Yao; Shao-Peng Li; Bai-Chao Ren
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

4.  Relaxing retinotomies and retinectomies in the management of retinal detachment with severe proliferative vitreoretinopathy (PVR).

Authors:  Khaled Ag Shalaby
Journal:  Clin Ophthalmol       Date:  2010-10-05

5.  Results of modified CO2 laser-assisted sclerectomy monotherapy versus trabeculectomy combination therapy in the eyes with uveitic glaucoma.

Authors:  Junyan Xiao; Chan Zhao; Yang Zhang; Yi Qu; Anyi Liang; Meifen Zhang; Gangwei Cheng
Journal:  Lasers Med Sci       Date:  2021-05-18       Impact factor: 3.161

6.  Outcomes of 23-gauge pars plana vitrectomy combined with phacoemulsification and capsulotomy without intraocular lens implantation in rhegmatogenous retinal detachment associated with choroidal detachment.

Authors:  Huiyan Xu; David Lutrin; Zhifeng Wu
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  Characterization of cyclitic membranes by ultrabiomicroscopy in patients with pars planitis.

Authors:  Luz Elena Concha Del Río; Gonzalo Alejandro Duarte González; Mariana Mayorquín Ruiz; Lourdes Arellanes-García
Journal:  J Ophthalmic Inflamm Infect       Date:  2020-01-27

8.  Ultrasound biomicroscopy as a tool in the evaluation and management of ocular hypotony in uveitis.

Authors:  Sudha K Ganesh; Nivedita Nair; Divya Thatikonda
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

9.  Intraocular endoscopy for the evaluation and treatment of hypotony due to a traumatic cyclodialysis: a case report.

Authors:  Henry Bair; Chun-Ju Lin; Chun-Ting Lai; Ning-Yi Hsia; Yi-Yu Tsai
Journal:  BMC Ophthalmol       Date:  2020-03-23       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.